Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 119
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Investigating the epidemiology of elephant endotheliotropic herpesvirus in Myanmar

Elephant endotheliotropic herpesvirus hemorrhagic disease (EEHV-HD) is the leading cause of death of young Asian...

Circulating biomarkers of fibrosis in captive gorillas: a pilot study

Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project is...

Backer Badge Funded